Keyword Analysis & Research: imatinib vs imatinib mesylate

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
imatinib vs imatinib mesylate	0.37	0.6	9136	62	29
imatinib	1.91	1	6056	34	8
vs	0.86	0.8	956	85	2
imatinib	1.96	0.2	7174	34	8
mesylate	0.02	0.5	1390	91	8

Keyword	CPC	PCC	Volume	Score
imatinib vs imatinib mesylate	0.65	0.7	9641	99
what is imatinib mesylate	0.29	0.2	781	77
imatinib mesylate drug classification	1.62	0.9	625	49
imatinib mesylate drug class	1.73	0.9	2185	33
imatinib mesylate cas no	0.49	0.9	2184	39
is imatinib mesylate chemotherapy	0.34	0.3	1718	4
imatinib mesylate usp monograph	0.11	0.6	7241	75
imatinib mesylate 100 mg	0.79	0.1	3436	70
imatinib mesylate brand name	0.86	0.9	623	50
imatinib mesylate molecular weight	1.61	0.7	1151	73
imatinib mesylate 400 mg	1.26	0.4	1938	86
imatinib mesylate mechanism of action	0.38	1	6182	78
cost of imatinib mesylate 400 mg	1.24	0.7	8201	39
imatinib mesylate generic name	0.92	0.9	1247	18
imatinib mesylate 400 mg price	1.27	0.1	2932	81
imatinib mesylate manufacturer in india	1.23	0.2	2393	10
imatinib mesylate 400 mg tab	0.37	0.9	1791	77
side effects of imatinib mesylate	1.39	0.3	1452	24
imatinib mesylate copay assistance	1.06	0.6	9687	49
imatinib mesylate copay card	1.15	0.7	80	8
imatinib modality of action	1.35	0.6	4366	13
imatinib-resistant	1.69	0.1	3879	64

Imatinib - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Imatinib

The "beta crystalline form" of the molecule is a specific polymorph of imatinib mesylate; a specific way that the individual molecules pack together to form a solid. This is the actual form of the drug sold as Gleevec/Glivec; a salt (imatinib mesylate) as opposed to a free base, and the beta crystalline form as opposed to the alpha or other form.… See more

DA: 29 PA: 54 MOZ Rank: 94

Imatinib
bing.com

https://www.bing.com/search?FORM=hlthdr&q=chronic+eosinophilic+leukemia

Common brand names: GleevecOVERVIEWSIDE EFFECTSINTERACTIONSDOSAGEThis medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Avoid getting pregnant or use when pregnant/nursing Take with a full glass of water (8 ounces) Swallow whole tablet. Do not break, chew or crush. Call MD if new abdominal pain/yellowing eyes/skin Call Dr if you have black stools or stomach pain Avoid infections and recently immunized people May make you drowsy or dizzy. Drive with caution Review all drugs you are taking with your doctor

Avoid getting pregnant or use when pregnant/nursing
Take with a full glass of water (8 ounces)
Swallow whole tablet. Do not break, chew or crush.
Call MD if new abdominal pain/yellowing eyes/skin
Call Dr if you have black stools or stomach pain
Avoid infections and recently immunized people
May make you drowsy or dizzy. Drive with caution
Review all drugs you are taking with your doctor

DA: 86 PA: 63 MOZ Rank: 55

Imatinib Mesylate - NCI - National Cancer Institute
cancer.gov

https://www.cancer.gov/about-cancer/treatment/drugs/imatinibmesylate

DA: 89 PA: 16 MOZ Rank: 73

Imatinib Mesylate - NCI - National Cancer Institute
cancer.gov

https://www.cancer.gov/about-cancer/treatment/drugs/imatinibmesylate

WebPosted: October 5, 2006. Updated: December 1, 2023. This page contains brief information about imatinib mesylate and a collection of links to more information about the use of …

DA: 17 PA: 2 MOZ Rank: 74

Frequently Asked Questions About Gleevec® …
cancerconnect.com

https://news.cancerconnect.com/treatment-care/frequently-asked-questions-about-gleevec-imatinib-mesylate

WebMar 17, 2020 · Imatinib mesylate inhibits the growth signaling processes, suppressing replication and ultimately causing death of Philadelphia-chromosome positive chronic myeloid leukemia cells. Imatinib mesylate …

DA: 3 PA: 78 MOZ Rank: 65

Current evidence on the efficacy and safety of generic …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525239/

WebSep 9, 2021 · Both in vitro and in vivo studies of generic imatinib showed comparable results with branded imatinib in terms of bioequivalence and bioavailability. In most … Author: Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Ahmet Emre Eşkazan DOI: 10.1182/bloodadvances.2021004194 Publish Year: 2021 Publication: Blood Adv. 2021 Sep 14; 5(17): 3344-3353.

Author: Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Ahmet Emre Eşkazan
DOI: 10.1182/bloodadvances.2021004194
Publish Year: 2021
Publication: Blood Adv. 2021 Sep 14; 5(17): 3344-3353.

DA: 49 PA: 57 MOZ Rank: 71

Imatinib: A Breakthrough of Targeted Therapy in Cancer
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055302/

WebMay 19, 2014 · In a phase III randomized trial involving 746 patients with advanced incurable GIST, 800 mg Imatinib was not found to be superior to 400 mg Imatinib as primary … Author: Nida Iqbal, Naveed Iqbal Publish Year: 2014

Author: Nida Iqbal, Naveed Iqbal
Publish Year: 2014

DA: 3 PA: 19 MOZ Rank: 64

Efficacy and Safety of Imatinib Mesylate in Advanced …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa020461

WebAug 15, 2002 · Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclinical models and preliminary clinical studies to have activity against such tumors.

DA: 15 PA: 78 MOZ Rank: 92

Imatinib - StatPearls - NCBI Bookshelf - National Center …
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK551676/

WebJun 20, 2023 · Continuing Education Activity. Imatinib is a 2-phenylamino-pyrimidine derivative protein that is a medication used to manage and treat chronic myelogenous leukemia, gastrointestinal stromal tumors, and …

DA: 67 PA: 88 MOZ Rank: 79

Mechanisms of Action of Imatinib Mesylate - American …
aacrjournals.org

https://aacrjournals.org/clincancerres/article/9/4/1248/202347/Understanding-the-Molecular-Basis-of-Imatinib

WebApr 1, 2003 · It has been shown that AGP binds imatinib mesylate at physiological concentrations in vitro and in vivo, and blocks the ability of imatinib mesylate to inhibit …

DA: 23 PA: 45 MOZ Rank: 42